Needham Reiterates Hold on Medtronic
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson has reiterated a Hold rating on Medtronic (NYSE:MDT).

August 12, 2024 | 9:31 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Needham analyst Mike Matson has reiterated a Hold rating on Medtronic (NYSE:MDT).
The reiteration of a Hold rating suggests that the analyst does not see significant upside or downside potential in the short term. This is likely to result in a neutral impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100